Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Science and Technology Development Project of Jilin Province (3D5177723429)
Science and Technology of Jilin Province, Jilin Province Key Laboratory (3D517K363429)
The Role and Molecular Mechanism of EMT in the Resistance of ROS1-positive Lung Cancer (20180101014JC)
- License Information
-
More Information
Article History
Received: 11 September 2019
Accepted: 7 November 2019
First Online: 18 November 2019
Ethics approval and consent to participate
: This study was approved by ethics committee of The Second Hospital of Jilin University (Changchun, China). Written informed consent was also obtained from all patients.
: Not applicable.
: The authors declare that they have no competing interests.
